Overview


According to FutureWise analysis the market for Nasal Spray in 2023 is US$ 17.98 billion, and is expected to reach US$ 29.59 billion by 2031 at a CAGR of 6.42%.

The nasal sprays are liquid medicines that are sprayed into the nostrils. In addition to reducing nasal congestion, they can also help reduce puffiness. As a result of allergies or a cold, congestion is a common symptom. A nasal spray is available over-the-counter or as a prescription medication. Additionally, they are available in two different packaging options: pressurised canisters and pump bottles. It provides information on recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, and market share, as well as new revenue opportunities. Regulation changes, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, and technological innovation. Nasal sprays are effective at treating blocked noses, delivering drugs efficiently, and treating nasal allergies. Nasal allergies can cause symptoms such as postnasal drip, fever, coughing, and bad breath. Treatment of nasal allergies, blocked noses, and efficient drug delivery for allergies can be accomplished with nasal sprays. Nasal allergies can lead to conditions such as fever, coughing, bad breath, and postnasal drip. As a result of the many benefits of nasal sprays, such as painless and effective drug delivery, improved convenience for patients, and easy accessibility, the nasal spray market is predicted to grow during the forecast period. Nasal sprays are also convenient, easy to use, and offer needle-free administration of drugs. The nose is considered the best route for administering medicine. The quick and direct administration of medication through the nose has a strong impact on a patient's respiratory organs. Putting medicine into the body or clearing the nose with a mass of very small drops of liquid: They make a flu vaccine as a nasal spray. Congestion in the nose can be relieved with a saline nasal spray. The nasal spray shrinks the blood vessels and tissues in the sinuses, which can become swollen and inflamed as a result of colds, allergies, and the flu. You should point the nasal spray toward the back of your nose so you can inhale the medicine properly.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Nasal Spray Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Nasal Spray Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • AstraZeneca Plc.
  • Cipla Ltd.
  • Johnson & Johnson Services, Inc. (Johnson & Johnson Pacific Pty Limited)
  • Glaxosmithkline Plc.
  • Novartis International AG
  • Procter & Gamble
  • Sanofi S.A. (Sanofi-aventis LLC.)
  • Boehringer Ingelheim GmbH
  • AdvaCare Pharma
  • Bayer AG (Bayer Consumer Health)
  • Covis Pharma S.a.r.l.
  • Nipro Corporation (NIPRO JMI Pharma Ltd.)
  • Viatris Inc. (Meda Pharmaceuticals Inc.)
  • Perrigo Company plc
  • AptarGroup, Inc.
  • Berry Global, Inc.
  • URSATEC GmbH
  • Gerresheimer AG
  • Bona
  • Avantor, VWR International, LLC
  • Spectrum Laboratory Products, Inc. (Spectrum Pharmacy Products)
  • SKS Bottle and Packaging, Inc.
  • Coster Tecnologie Speciali S.p.A

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Decongestant Sprays
  • Nasal Steroid Sprays
  • Nasal Antihistamine Sprays
  • Nasal Cromolyn Sodium Sprays
  • Nasal Anticholinergic Sprays
  • Nasal Triamcinolone Sprays

By Formulation

  • Aqueous
  • Hydroalcoholic
  • Nonaqueous-Based Solution
  • Suspension
  • Emulsions
  • Dry Powder/Micro particles

By Packaging

  • Pressurized Canisters
  • Pump Bottles

By Distribution Channel

  • Institutional Sales
    • Hospitals
    • Community Clinics
    • Specialty Clinics
    • Public Health Agencies
    • Veterinary Hospitals and Clinics
  • Retail Sales
    • Retail Pharmacies
    • Drug Stores
    • Mail Order Pharmacy

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Nasal Spray Market By Product, By Formulation, By Packaging, By Distribution Channel and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Nasal Spray Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Nasal Spray Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Nasal Spray Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Nasal Spray Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Decongestant Sprays
        2. Nasal Steroid Sprays
        3. Nasal Antihistamine Sprays
        4. Nasal Cromolyn Sodium Sprays
        5. Nasal Anticholinergic Sprays
        6. Nasal Triamcinolone Sprays

  • 8.   Nasal Spray Market, By Formulation Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Aqueous
        2. Hydroalcoholic
        3. Nonaqueous-Based Solution
        4. Suspension
        5. Emulsions
        6. Dry Powder/Micro particles

  • 9.   Nasal Spray Market, By Packaging Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pressurized Canisters
        2. Pump Bottles

  • 10.   Nasal Spray Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Institutional Sales
         1.1. Hospitals
         1.2. Community Clinics
         1.3. Specialty Clinics
         1.4. Public Health Agencies
         1.5. Veterinary Hospitals and Clinics
        2. Retail Sales
         2.1. Retail Pharmacies
         2.2. Drug Stores
         2.3. Mail Order Pharmacy

  • 11.   North America Nasal Spray Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Nasal Spray Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Nasal Spray Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Nasal Spray Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Nasal Spray Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. AstraZeneca Plc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Cipla Ltd.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Johnson & Johnson Services, Inc. (Johnson & Johnson Pacific Pty Limited)
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Glaxosmithkline Plc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Novartis International AG
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Procter & Gamble
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Sanofi S.A. (Sanofi-aventis LLC.)
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Boehringer Ingelheim GmbH
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. AdvaCare Pharma
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Bayer AG (Bayer Consumer Health)
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Covis Pharma S.a.r.l.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Nipro Corporation (NIPRO JMI Pharma Ltd.)
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Viatris Inc. (Meda Pharmaceuticals Inc.)
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Perrigo Company plc
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. AptarGroup, Inc.
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Berry Global, Inc.
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. URSATEC GmbH
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. Gerresheimer AG
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. Bona
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20. Avantor, VWR International, LLC
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview
        21. Spectrum Laboratory Products, Inc. (Spectrum Pharmacy Products)
         21.1. Company Overview
         21.2. Product Portfolio
         21.3. SWOT Analysis
         21.4. Financial Overview
         21.5. Strategic Overview
        22. SKS Bottle and Packaging, Inc.
         22.1. Company Overview
         22.2. Product Portfolio
         22.3. SWOT Analysis
         22.4. Financial Overview
         22.5. Strategic Overview
        23. Coster Tecnologie Speciali S.p.A
         23.1. Company Overview
         23.2. Product Portfolio
         23.3. SWOT Analysis
         23.4. Financial Overview
         23.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients